Chalcogen-bond engineered redox-responsive nano-prodrugs for anticancer therapy.

The distinct redox imbalance in malignant cells, characterized by elevated reactive oxygen species and glutathione levels compared to normal tissues, establishes a therapeutic window for chemotherapeutic intervention through exploitation of the tumor…

Preview only. Read the full abstract at the source